Shares of Gilead Sciences, Inc. (GILD) traded over 1% lower on Tuesday noon after the company said that the U.S. Food and ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Find lists of blood pressure medications commonly used to treat hypertension and the names of medications prescribed less ...

Improvements in health care in Eswatini have relied for years on Pepper and the generosity of the American people. During the ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

Staffers at the remnants of the United States Agency for International Development (USAID), the foreign aid agency dismantled ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Since then, scientists have made astonishing progress in their understanding of AIDS and its underlying ... more than one in five new HIV infections — 22 percent. Drug users who became infected ...

"I would single out aspirin from all the other [drugs of its class]," Benet says. Stone and Greenberg note that aspirin is having a revival. It fights inflammation, a process at the core of heart ...

SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

Typical treatment options for MS patients involve immunomodulatory drugs, which act nonspecifically, resulting in global immunosuppression. The study discussed herein aims to demonstrate the efficacy ...